1KFU | L:544-604; S:811-870 | CRYSTAL STRUCTURE OF HUMAN M-CALPAIN FORM II |
1KFX | L:544-604; S:811-870 | CRYSTAL STRUCTURE OF HUMAN M-CALPAIN FORM I |
1M39 | A:117-165 | SOLUTION STRUCTURE OF THE C-TERMINAL FRAGMENT (F86-I165) OF THE HUMAN CENTRIN 2 IN CALCIUM SATURATED FORM |
2K2I | A:117-169 | NMR SOLUTION STRUCTURE OF THE C-TERMINAL DOMAIN (T94-Y172) OF THE HUMAN CENTRIN 2 IN COMPLEX WITH A REPEAT SEQUENCE OF HUMAN SFI1 (R641-T660) |
2OBH | B:117-168; B:117-168 | CENTRIN-XPC PEPTIDE |
1WLZ | D:234-277; D:234-277; D:234-277; D:234-277 | CRYSTAL STRUCTURE OF DJBP FRAGMENT WHICH WAS OBTAINED BY LIMITED PROTEOLYSIS |
1S1E | A:65-118 | CRYSTAL STRUCTURE OF KV CHANNEL-INTERACTING PROTEIN 1 (KCHIP-1) |
1TTX | A:70-109 | SOLUTION STRUCTURE OF HUMAN BETA PARVALBUMIN (ONCOMODULIN) REFINED WITH A PARAMAGNETISM BASED STRATEGY |
2ZN8 | A:39-90 | CRYSTAL STRUCTURE OF ZN2+-BOUND FORM OF ALG-2 |
2ZN9 | B:39-90; B:39-90 | CRYSTAL STRUCTURE OF CA2+-BOUND FORM OF DES3-20ALG-2 |
2ZND | A:39-90 | CRYSTAL STRUCTURE OF CA2+-FREE FORM OF DES3-20ALG-2 |
2ZNE | B:39-90; B:39-90 | CRYSTAL STRUCTURE OF ZN2+-BOUND FORM OF DES3-23ALG-2 COMPLEXED WITH ALIX ABS PEPTIDE |
2ZRS | H:39-90; H:39-90; H:39-90; H:39-90; H:39-90; H:39-90; H:39-90; H:39-90 | CRYSTAL STRUCTURE OF CA2+-BOUND FORM OF DES3-23ALG-2 |
2ZRT | H:39-90; H:39-90; H:39-90; H:39-90; H:39-90; H:39-90; H:39-90; H:39-90 | CRYSTAL STRUCTURE OF ZN2+-BOUND FORM OF DES3-23ALG-2 |
1RJV | A:67-110 | SOLUTION STRUCTURE OF HUMAN ALPHA-PARVALBUMIN REFINED WITH A PARAMAGNETISM-BASED STRATEGY |
1RK9 | A:67-109 | SOLUTION STRUCTURE OF HUMAN ALPHA-PARVALBUMIN (MINIMIZED AVERAGE STRUCTURE) |
1JUO | B:45-102; B:45-102 | CRYSTAL STRUCTURE OF CALCIUM-FREE HUMAN SORCIN: A MEMBER OF THE PENTA-EF-HAND PROTEIN FAMILY |
2JC2 | D:45-102; D:45-102; D:45-102; D:45-102 | THE CRYSTAL STRUCTURE OF THE NATURAL F112L HUMAN SORCIN MUTANT |
1LXF | C:32-84 | STRUCTURE OF THE REGULATORY N-DOMAIN OF HUMAN CARDIAC TROPONIN C IN COMPLEX WITH HUMAN CARDIAC TROPONIN-I(147-163) AND BEPRIDIL |
1MXL | C:32-84 | STRUCTURE OF CARDIAC TROPONIN C-TROPONIN I COMPLEX |
1OZS | A:117-159 | C-DOMAIN OF HUMAN CARDIAC TROPONIN C IN COMPLEX WITH THE INHIBITORY REGION OF HUMAN CARDIAC TROPONIN I |
1SPY | A:32-84 | REGULATORY DOMAIN OF HUMAN CARDIAC TROPONIN C IN THE CALCIUM-FREE STATE, NMR, 40 STRUCTURES |
1WRK | B:32-84; B:32-84 | CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN CARDIAC TROPONIN C IN COMPLEX WITH TRIFLUOPERAZINE (ORTHROMBIC CRYSTAL FORM) |
1WRL | F:32-84; F:32-84; F:32-84; F:32-84; F:32-84; F:32-84 | CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN CARDIAC TROPONIN C IN COMPLEX WITH TRIFLUOPERAZINE (MONOCLINIC CRYSTAL FORM) |
2JT0 | A:117-159; A:117-159 | SOLUTION STRUCTURE OF F104W CARDIAC TROPONIN C |
2JT3 | A:117-159; A:117-159 | SOLUTION STRUCTURE OF F153W CARDIAC TROPONIN C |
2JT8 | A:117-159; A:117-159 | SOLUTION STRUCTURE OF THE F153-TO-5-FLUROTRYPTOPHAN MUTANT OF HUMAN CARDIAC TROPONIN C |
2JTZ | A:117-159; A:117-159 | SOLUTION STRUCTURE AND CHEMICAL SHIFT ASSIGNMENTS OF THE F104-TO-5-FLUROTRYPTOPHAN MUTANT OF CARDIAC TROPONIN C |
2JXL | A:32-84 | SOLUTION STRUCTURE OF CARDIAC N-DOMAIN TROPONIN C MUTANT F77W-V82A |
2KFX | T:32-84 | STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN CARDIAC TROPONIN C BOUND TO CALCIUM ION AND TO THE INHIBITOR W7 |
2KGB | C:32-84 | NMR SOLUTION OF THE REGULATORY DOMAIN CARDIAC F77W-TROPONIN C IN COMPLEX WITH THE CARDIAC TROPONIN I 144-163 SWITCH PEPTIDE |
2KRD | C:32-84 | SOLUTION STRUCTURE OF THE REGULATORY DOMAIN OF HUMAN CARDIAC TROPONIN C IN COMPLEX WITH THE SWITCH REGION OF CARDIAC TROPONIN I AND W7 |
2L1R | A:32-84 | THE STRUCTURE OF THE CALCIUM-SENSITIZER, DFBP-O, IN COMPLEX WITH THE N-DOMAIN OF TROPONIN C AND THE SWITCH REGION OF TROPONIN I |
2L98 | A:117-159 | STRUCTURE OF TRANS-RESVERATROL IN COMPLEX WITH THE CARDIAC REGULATORY PROTEIN TROPONIN C |